ID   UoC-M1
AC   CVCL_A480
SY   UOC-M1; UOCM1
DR   cancercelllines; CVCL_A480
DR   Cosmic; 975311
DR   DSMZ; ACC-775
DR   DSMZCellDive; ACC-775
DR   GEO; GSM1040774
DR   Progenetix; CVCL_A480
DR   Wikidata; Q54991265
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9665199;
RX   PubMed=14671638;
RX   PubMed=36982453;
CC   Doubling time: ~50-60 hours (DSMZ=ACC-775).
CC   Misspelling: UCM1; GEO=GSM1040774.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-775
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 17,19
ST   D19S433: 11
ST   D21S11: 28
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 5,7
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=9665199; DOI=10.1038/sj.leu.2401002;
RA   Allen, Rudy J.
RA   Smith, Stephen D.
RA   Moldwin, Richard L.
RA   Lu, Min-Min
RA   Giordano, Lisa
RA   Vignon, Clementine
RA   Suto, Yoshimasa
RA   Harden, Alanna M.
RA   Tomek, Ronald
RA   Veldman, Tim
RA   Ried, Thomas
RA   Larson, Richard A.
RA   Le Beau, Michelle M.
RA   Rowley, Janet Davison
RA   Zeleznik-Le, Nancy J.
RT   "Establishment and characterization of a megakaryoblast cell line with
RT   amplification of MLL.";
RL   Leukemia 12:1119-1127(1998).
//
RX   PubMed=14671638; DOI=10.1038/sj.leu.2403236;
RA   Drexler, Hans Gunther
RA   Quentmeier, Hilmar
RA   MacLeod, Roderick A.F.
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   MLL gene alterations.";
RL   Leukemia 18:227-232(2004).
//
RX   PubMed=36982453; DOI=10.3390/ijms24065377; PMCID=PMC10049680;
RA   Skopek, Rafal
RA   Palusinska, Malgorzata
RA   Kaczor-Keller, Katarzyna
RA   Pingwara, Rafal
RA   Papierniak-Wygladala, Anna
RA   Schenk, Tino
RA   Lewicki, Slawomir
RA   Zelent, Artur
RA   Szymanski, Lukasz
RT   "Choosing the right cell line for acute myeloid leukemia (AML)
RT   research.";
RL   Int. J. Mol. Sci. 24:5377.1-5377.34(2023).
//